“Rising Shift towards Minimally Invasive Procedures”
The global aortic stent grafts market is experiencing robust growth, driven by the increasing incidence of aortic aneurysms, cardiovascular diseases, and the rising geriatric population. A key trend shaping the market is the shift towards minimally invasive surgeries, as these devices offer a less traumatic alternative to traditional surgery. Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (TEVAR) have become increasingly preferred due to their ability to reduce recovery times and lower the risk of complications. Companies such as Medtronic and W.L. Gore & Associates are innovating with advanced stent graft designs, such as the GORE EXCLUDER AAA Endoprosthesis, which provides better durability and flexibility for treating abdominal aortic aneurysms. Additionally, advancements in biocompatible materials and customized grafts are enhancing device performance, contributing to the increasing adoption of aortic stent grafts in clinical settings. With growing healthcare investments in regions such as Asia-Pacific and North America, the market is expected to expand steadily.
